SCHRODER INVESTMENT MANAGEMENT GROUP - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,539,729
-69.2%
64,022
-59.1%
0.00%
-71.4%
Q2 2023$4,994,012
-37.0%
156,405
-39.6%
0.01%
-41.7%
Q1 2023$7,928,835
-5.2%
258,943
+21.1%
0.01%
-7.7%
Q4 2022$8,361,210
-16.7%
213,787
+1.5%
0.01%
-23.5%
Q3 2022$10,035,000
-10.9%
210,642
-24.4%
0.02%0.0%
Q2 2022$11,257,000278,5040.02%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders